As filed with the Securities and Exchange Commission on February 16, 2005
File No. 333-68268
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8/A
POST-EFFECTIVE
AMENDMENT NO. 1
TO
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Abbott Laboratories
(Exact Name of Registrant as Specified in Its Charter)
|
Illinois |
|
36-0698440 |
|
(State or Other Jurisdiction |
|
(I.R.S. Employer |
100 Abbott Park Road
Abbott Park, Illinois 60064-6400
(Address of Principal Executive Offices) (Zip Code)
Abbott Laboratories 401(k) Plan
(Full Title of the Plan)
Jose M. de Lasa
Abbott Laboratories
100 Abbott Park Road
Abbott Park, Illinois 60064-6400
(Name and Address of Agent For Service)
(847) 937-5200
(Telephone Number, Including Area Code, of Agent For Service)
De-Registration of Common Shares and Plan Interests
On August 24, 2001, Abbott Laboratories (“Abbott”) registered 300,000 common shares, without par value, of Abbott Laboratories and an indeterminate amount of plan interests on a Registration Statement on Form S-8 (file number 333-68268) under the Securities Act of 1933 (the “Registration Statement”), to be issued pursuant to the Abbott Laboratories 401(k) Plan (the “Plan”). Abbott has now merged the Plan with and into the Abbott Laboratories Stock Retirement Program. As a result, all offerings by Abbott of Abbott common shares and related Plan interests pursuant to the Registration Statement have terminated.
In accordance with Abbott’s undertaking in the Registration Statement to remove from registration, by means of a post-effective amendment, any of the securities that remain unsold at the termination of the offering, Abbott hereby withdraws the 131,351 common shares and related Plan interests that remain unsold under the Plan as of the date of this post-effective Amendment.
2
SIGNATURES
THE REGISTRANT. Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this post-effective amendment to the registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in unincorporated Lake County, State of Illinois on this 16th day of February, 2005.
|
|
ABBOTT LABORATORIES |
||
|
|
|
||
|
|
|
||
|
|
By: |
/s/ Jose M. de Lasa |
|
|
|
|
Jose M. de Lasa |
|
|
|
|
Executive Vice President and General Counsel |
|
3
Pursuant to the requirements of the Securities Act of 1933, this post-effective amendment to the registration statement has been signed by the following persons in the capacities and on the dates indicated.
|
|
|
Chairman of the Board, |
|
February 16, 2005 |
|
* |
|
Chief Executive Officer, and |
|
|
|
Miles D. White |
|
Director |
|
|
|
|
|
|
|
|
|
|
|
President and Chief |
|
|
|
|
|
Operating Officer, |
|
February 16, 2005 |
|
* |
|
Medical Products Group, |
|
|
|
Richard A. Gonzalez |
|
and Director |
|
|
|
|
|
|
|
|
|
|
|
President and Chief Operating |
|
February 16, 2005 |
|
* |
|
Officer, Pharmaceutical Products |
|
|
|
Jeffrey M. Leiden |
|
Group, and Director |
|
|
|
|
|
|
|
|
|
|
|
Executive Vice President, Finance and |
|
February 16, 2005 |
|
/s/ Thomas C. Freyman |
|
Chief Financial Officer (Principal |
|
|
|
Thomas C. Freyman |
|
Financial Officer) |
|
|
|
|
|
|
|
|
|
|
|
Vice President and Controller |
|
February 16, 2005 |
|
/s/ Greg W. Linder |
|
(Principal Accounting Officer) |
|
|
|
Greg W. Linder |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
February 16, 2005 |
|
Roxanne S. Austin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Director |
|
February 16, 2005 |
|
William M. Daley |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
February 16, 2005 |
|
H. Laurance Fuller |
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
February 16, 2005 |
|
Jack M. Greenberg |
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
February 16, 2005 |
|
David A. L. Owen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
February 16, 2005 |
|
Boone Powell Jr. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
February 16, 2005 |
|
A. Barry Rand |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
February 16, 2005 |
|
W. Ann Reynolds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
February 16, 2005 |
|
Roy S. Roberts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
February 16, 2005 |
|
William D. Smithburg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
February 16, 2005 |
|
John R. Walter |
|
|
|
|
|
*By: |
|
|
|
|
|
|
/s/ Jose M. de Lasa |
|
|
|
|
|
Jose M. de Lasa, Esq. |
|
|
|
|
|
Attorney-In-Fact |
|
|
|
5
THE PLAN. Pursuant to the requirements of the Securities Act of 1933, the Abbott Laboratories Stock Retirement Program, successor-in-interest to Abbott Laboratories 401(k) Plan, has duly caused this post-effective amendment to the registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in unincorporated Lake County, State of Illinois on this 16thday of February, 2005.
|
|
ABBOTT LABORATORIES STOCK |
|||
|
|
|
|
||
|
|
By: |
Abbott Laboratories Employee Benefit |
||
|
|
|
|
||
|
|
|
|
||
|
|
|
/s/ Thomas C. Freyman |
|
|
|
|
|
Thomas C. Freyman |
||
|
|
|
|
||
|
|
|
|
||
|
|
|
/s/ Greg W. Linder |
|
|
|
|
|
Greg W. Linder |
||
|
|
|
|
||
|
|
|
|
||
|
|
|
/s/ Thomas M. Wascoe |
|
|
|
|
|
Thomas M. Wascoe |
||
6
EXHIBIT INDEX
|
Exhibit Number |
|
Description |
|
|
|
|
|
24 ** |
|
Power of Attorney |
** Incorporated herein by reference. Commission file number 333-68268.
7